Abstract
specific survival (CSS) was 83%, and two year overall survival (OS) was 69%. In the palliative group, the two year CSS and OS were 28.2%, with a median survival of 15 months. Conclusions: IMRT using daily image guidance is a feasible approach in the treatment of advanced bladder cancer, with promising loco-regional control and toxicity. Technical difficulties in the placement of fiducial markers need to be addressed. Author Disclosure: D.M. Whalley: None. H. Caine: None. L. Guo: None. A. Kneebone: None. T. Eade: None.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
